Industry | 2018.10.03
Cognate BioServices and Terumo BCT Announce Letter of Intent for Collaboration Agreement for Innovation and Development Center of Excellence in Memphis, TN.
MEMPHIS, Tenn., Oct. 3, 2018 /PRNewswire/ -- Cognate BioServices, a leading contract development and manufacturing organization ("CDMO") in the global cellular therapies industry, today announced a letter of intent for a collaboration agreement with Terumo BCT, a leading technology...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]e-in-memphis-tn-300723292.html
